Melanotan II, LL-37, and PEG-MGF were taken off the Category 2 list in April 2026, so they are no longer on it, even though they still cannot be compounded
Increased ventricles and sulcal dilatation are a consequence of neuron degeneration within the brain
Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis
Regular monitoring is essential for both treatments to adjust dosing, assess GH levels, and manage potential side effects such as water retention, joint pain, or insulin resistance over time
Today, we rely on two revolutionary variants that have changed the landscape of muscle healing and kinetic optimization: IGF-1LR3 and IGF-DES
30 day supply of injections $249 Consultation reviewed and prescribed by our medical team